UNSPSC 51422311: Mazipredone

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H38N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QN0W2YSW63, chemically known as 11beta,17-dihydroxy-21-(4-methyl-1-piperazinyl)pregna-1,4-diene-3,20-dione. but generally known as mazipredone, which bears US NIH Compound Identifier 6064. European Medicines Agency schedules Mazipredone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08657MIG.

UNSPSC 51422311 Mazipredone is a Commodity code that does not match the work actually being solicited under it in recent state and local procurement activity. The single recent opportunity in the dataset—Seminole County, Florida's IFB for naloxone and drug deactivation systems—involves over-the-counter emergency medical supplies and harm-reduction devices, not a branded pharmaceutical product. The code appears to have been applied to this solicitation in error or represents a legacy classification mismatch. The Seminole County procurement itself seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; vendors must cover all shipping and delivery costs and comply with drug-free workplace certification, E-Verify requirements, and federal regulations including the Clean Air Act and Federal Water Pollution Control Act, with potential FEMA funding implications.

The code shows little relevant recent activity for business development purposes. The single posted opportunity does not reflect a genuine market for mazipredone procurement at the state and local level. Firms pursuing pharmaceutical or emergency medical supply contracts should verify the correct UNSPSC code before positioning for opportunities—this code's classification appears unreliable as a targeting mechanism for naloxone or related products.